Heat and humidity contributed to kidney damage and disease in the San Luis Valley in Colorado between 1984 and 1998, ...

Dr. Allen Davidoff, CEO of XORTX stated, “This patent covers compositions of formulations key to XORTX’s platform technology and this issuance strengthens our intellectual property portfolio in the ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Volatile organic compounds (VOCs) are metabolic byproducts reflecting pathophysiologic processes and have been widely utilized as non-invasive biomarkers for disease differentiation. While VOCs have ...

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

Extended exposure to drought conditions coupled with inadequate water intake has been linked to kidney stones, acute kidney ...

The researchers found that people with higher DII scores—meaning they ate more inflammatory foods—were 36% more likely to ...

More than 35 million adults in the U.S. have chronic kidney disease, and just a fraction of them even know it. And the number ...

The use of Renalytix plc’s Kidneyintelx biomarker-based prognostic test led to increased and targeted use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients at risk of diabetic kidney ...

Diuretic use does not affect safety and efficacy outcomes in patients with type 2 diabetes and chronic kidney disease receiving finerenone.

Diabetic nephropathy (DN), characterized by progressive damage to the glomeruli and tubulointerstitial compartments, is ...

Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for ...